KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules.

Area of Science:

• Immunology
• Cellular Signaling

Background:

• Killer cell Ig-like receptors (KIRs) are crucial for NK cell function.
• KIR2DL4 (2DL4) mediates cytokine production and cytolysis, but its signaling mechanism is poorly understood.

Purpose of the Study:

• To elucidate the signaling pathways activated by 2DL4 engagement in human NK cells.
• To identify the structural domains responsible for 2DL4-mediated signaling and effector functions.

Main Methods:

• Utilized a human NK-like cell line (KHYG-1).
• Employed cross-linking of 2DL4, pharmacological inhibitors of signaling pathways (MAPKs, NF-kappaB), and site-directed mutagenesis (R/G mutant).
• Assessed MAPK activation (JNK, ERK, p38), NF-kappaB pathway activation (IKKbeta, IkappaBalpha), cytokine gene expression, and receptor-ligand interactions (FcepsilonRI-gamma).

Main Results:

• 2DL4 engagement activated MAPKs (JNK, ERK, p38) and the NF-kappaB pathway.
• MAPK activation was upstream of NF-kappaB activation.
• Inhibition of MAPKs blocked specific cytokine production (IFN-gamma, IL-8, MIP1alpha).
• A transmembrane mutant (R/G) abrogated FcepsilonRI-gamma association and cytolytic activity but retained MAPK/NF-kappaB activation and MIP1alpha production.
• Distinct structural modules of 2DL4 mediate different signaling outputs.

Conclusions:

• 2DL4 activates potent cytokine production through MAPK and NF-kappaB signaling.
• The transmembrane arginine residue is critical for FcepsilonRI-gamma association and downstream signaling, but not for all 2DL4-mediated functions.
• 2DL4 possesses at least two distinct structural modules for activating signaling pathways and effector functions.